Skip to main content
Erschienen in: Rheumatology International 10/2008

01.08.2008 | Original Article

Catalase −262C>T polymorphism in systemic lupus erythematosus in Poland

verfasst von: Teresa Warchoł, Margarita Lianeri, Mariusz Wudarski, Jan K. Łącki, Paweł P. Jagodziński

Erschienen in: Rheumatology International | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

It has been reported that reactive oxygen species contribute to pathogenesis of systemic lupus erythematosus (SLE). Catalase (CAT) −330C>T transition, known also as −262C>T, generates three genotypes. The CAT −330CC genotype is associated with a significantly lower CAT expression in comparison to −330CT and −330CT genotypes. Therefore, using restriction length fragment polymorphism analysis, we compared the frequencies of CAT −330C>T polymorphic variants between SLE patients (n = 102) and controls (n = 199). We did not observe significant differences in the prevalence of CAT −330C>T polymorphic variants in SLE patients and controls. However, we found that the CAT −330CC genotype (recessive model) showed a significant association with thrombocytopenia OR = 7.314 (1.977–27.057, P = 0.0017). We also observed that the CAT −330CC genotype (recessive model) is linked with leukopenia OR = 3.232 (1.361–7.676, P = 0.0118), renal manifestations OR = 2.403 (1.085–5.321, P = 0.0471) and presence of anti-snRNP Ab OR = 4.206 (95% CI = 1.405–12.590, P = 0.0131), and anti-Scl-70 Ab, OR = 3.143 (95% CI = 1.171–8.433, P = 0.0343) in SLE patients. Our findings suggest that the CAT −330CC genotype may contribute to some clinical manifestations in patients with SLE.
Literatur
1.
Zurück zum Zitat Bauer V, Bauer F (1999) Reactive oxygen species as mediators of tissue protection and injury. Gen Physiol Biophys 18:7–14PubMed Bauer V, Bauer F (1999) Reactive oxygen species as mediators of tissue protection and injury. Gen Physiol Biophys 18:7–14PubMed
2.
Zurück zum Zitat Taysi S, Gul M, Sari RA, Akcay F, Bakan N (2002) Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin Chem Lab Med 40:684–688PubMedCrossRef Taysi S, Gul M, Sari RA, Akcay F, Bakan N (2002) Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin Chem Lab Med 40:684–688PubMedCrossRef
3.
Zurück zum Zitat Sekigawa I, Naito T, Hira K, Mitsuishi K, Ogasawara H, Hashimoto H, Ogawa H (2004) Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus 13:217–222PubMedCrossRef Sekigawa I, Naito T, Hira K, Mitsuishi K, Ogasawara H, Hashimoto H, Ogawa H (2004) Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus 13:217–222PubMedCrossRef
4.
Zurück zum Zitat Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef
5.
Zurück zum Zitat Piotrowski PC, Duriagin S, Jagodzinski PP (2005) Expression of human endogenous retrovirus clone 4–1 may correlate with blood plasma concentration of anti-U1 RNP and anti-Sm nuclear antibodies. Clin Rheumatol 24:620–624PubMedCrossRef Piotrowski PC, Duriagin S, Jagodzinski PP (2005) Expression of human endogenous retrovirus clone 4–1 may correlate with blood plasma concentration of anti-U1 RNP and anti-Sm nuclear antibodies. Clin Rheumatol 24:620–624PubMedCrossRef
6.
Zurück zum Zitat Januchowski R, Wudarski M, Chwalińska-Sadowska H, Jagodzinski PP (2007) Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4(+) T cells of patients with systemic lupus erythematosus. Clin Rheumatol. doi:10.1007/s10067-007-0644-8 Januchowski R, Wudarski M, Chwalińska-Sadowska H, Jagodzinski PP (2007) Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4(+) T cells of patients with systemic lupus erythematosus. Clin Rheumatol. doi:10.​1007/​s10067-007-0644-8
7.
Zurück zum Zitat Serban MG, Negru T (1998) Antioxidant protection in collagen-vascular diseases. Rom J Intern Med 36:245–250PubMed Serban MG, Negru T (1998) Antioxidant protection in collagen-vascular diseases. Rom J Intern Med 36:245–250PubMed
8.
Zurück zum Zitat Túri S, Németh I, Torkos A, Sághy L, Varga I, Matkovics B, Nagy J (1997) Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 22:161–168PubMedCrossRef Túri S, Németh I, Torkos A, Sághy L, Varga I, Matkovics B, Nagy J (1997) Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 22:161–168PubMedCrossRef
9.
Zurück zum Zitat Ahsan H, Ali A, Ali R (2003) Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol 131:398–404PubMedCrossRef Ahsan H, Ali A, Ali R (2003) Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol 131:398–404PubMedCrossRef
10.
Zurück zum Zitat Suryaprabha P, Das UN, Ramesh G, Kumar KV, Kumar GS (1991) Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids 43:251–255PubMedCrossRef Suryaprabha P, Das UN, Ramesh G, Kumar KV, Kumar GS (1991) Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids 43:251–255PubMedCrossRef
11.
Zurück zum Zitat Nuttall SL, Heaton S, Piper MK, Martin U, Gordon C (2003) Cardiovascular risk in systemic lupus erythematosus–evidence of increased oxidative stress and dyslipidaemia. Rheumatology 42:758–762PubMedCrossRef Nuttall SL, Heaton S, Piper MK, Martin U, Gordon C (2003) Cardiovascular risk in systemic lupus erythematosus–evidence of increased oxidative stress and dyslipidaemia. Rheumatology 42:758–762PubMedCrossRef
12.
Zurück zum Zitat Gergely P Jr, Grossman C, Niland B, Puskas F, Neupane H, Allam F, Banki K, Phillips PE, Perl A (2002) Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum 46:175–190PubMedCrossRef Gergely P Jr, Grossman C, Niland B, Puskas F, Neupane H, Allam F, Banki K, Phillips PE, Perl A (2002) Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum 46:175–190PubMedCrossRef
13.
Zurück zum Zitat Ahmad R, Alam K, Ali R (2000) Antigen-binding characteristics of antibodies against hydroxyl radical modified thymidine monophosphate. Immunol Lett 71:111–115PubMedCrossRef Ahmad R, Alam K, Ali R (2000) Antigen-binding characteristics of antibodies against hydroxyl radical modified thymidine monophosphate. Immunol Lett 71:111–115PubMedCrossRef
14.
Zurück zum Zitat Ashok BT, Ali R (1999) Antigen-binding characteristics of experimentally induced antibodies against hydroxyl radical modified native DNA. Autoimmunity 29:11–19PubMedCrossRef Ashok BT, Ali R (1999) Antigen-binding characteristics of experimentally induced antibodies against hydroxyl radical modified native DNA. Autoimmunity 29:11–19PubMedCrossRef
15.
Zurück zum Zitat Termaat RM, Brinkman K, van Gompel F, van den Heuvel LP, Veerkamp JH, Smeenk RJ, Berden JH (1990) Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun 3:531–545PubMedCrossRef Termaat RM, Brinkman K, van Gompel F, van den Heuvel LP, Veerkamp JH, Smeenk RJ, Berden JH (1990) Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun 3:531–545PubMedCrossRef
16.
Zurück zum Zitat Quan F, Korneluk RG, Tropak MB, Gravel RA (1986) Isolation and characterization of the human catalase gene. Nucleic Acids Res 14:5321–5335PubMedCrossRef Quan F, Korneluk RG, Tropak MB, Gravel RA (1986) Isolation and characterization of the human catalase gene. Nucleic Acids Res 14:5321–5335PubMedCrossRef
17.
Zurück zum Zitat Scofield RH, Bruner GR, Kelly JA, Kilpatrick J, Bacino D, Nath SK, Harley JB (2003) Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13. Blood 101:992–997PubMedCrossRef Scofield RH, Bruner GR, Kelly JA, Kilpatrick J, Bacino D, Nath SK, Harley JB (2003) Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13. Blood 101:992–997PubMedCrossRef
18.
Zurück zum Zitat Nilakantan V, Spear BT, Glauert HP (1998) Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate. Carcinogenesis 19:631–637PubMedCrossRef Nilakantan V, Spear BT, Glauert HP (1998) Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate. Carcinogenesis 19:631–637PubMedCrossRef
19.
Zurück zum Zitat Forsberg L, Lyrenäs L, de Faire U, Morgenstern R (2001) A common functional C–T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 30:500–505PubMedCrossRef Forsberg L, Lyrenäs L, de Faire U, Morgenstern R (2001) A common functional C–T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 30:500–505PubMedCrossRef
20.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef
21.
Zurück zum Zitat Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef
22.
Zurück zum Zitat Mostowska A, Hozyasz KK, Lianeri M, Piwowar W, Jagodzinski PP (2007) Polymorphic variants of genes encoding main antioxidant enzymes and the risk of CL/P-affected pregnancies. Clin Biochem 40:416–419PubMedCrossRef Mostowska A, Hozyasz KK, Lianeri M, Piwowar W, Jagodzinski PP (2007) Polymorphic variants of genes encoding main antioxidant enzymes and the risk of CL/P-affected pregnancies. Clin Biochem 40:416–419PubMedCrossRef
23.
Zurück zum Zitat Venkatraman JT, Chandrasekar B, Kim JD, Fernandes G (1994) Genotype effects on the antioxidant enzymes activity and mRNA expression in liver and kidney tissues of autoimmune-prone MRL/MpJ-lpr/lpr mice. Biochim Biophys Acta 1213:167–175PubMed Venkatraman JT, Chandrasekar B, Kim JD, Fernandes G (1994) Genotype effects on the antioxidant enzymes activity and mRNA expression in liver and kidney tissues of autoimmune-prone MRL/MpJ-lpr/lpr mice. Biochim Biophys Acta 1213:167–175PubMed
24.
Zurück zum Zitat Venkatraman JT, Chandrasekar B, Kim JD, Fernandes G (1994) Effects of n-3 and n-6 fatty acids on the activities and expression of hepatic antioxidant enzymes in autoimmune-prone NZB × NZW F1 mice. Lipids 8:561–568CrossRef Venkatraman JT, Chandrasekar B, Kim JD, Fernandes G (1994) Effects of n-3 and n-6 fatty acids on the activities and expression of hepatic antioxidant enzymes in autoimmune-prone NZB × NZW F1 mice. Lipids 8:561–568CrossRef
25.
Zurück zum Zitat Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS (2003) Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 48:2888–2897PubMedCrossRef Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS (2003) Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 48:2888–2897PubMedCrossRef
26.
Zurück zum Zitat Hepburn AL, Lampert IA, Boyle JJ, Horncastle D, Ng WF, Layton M, Vyse TJ, Botto M, Mason JC (2007) In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus. Ann Rheum Dis 66:1106–1109PubMedCrossRef Hepburn AL, Lampert IA, Boyle JJ, Horncastle D, Ng WF, Layton M, Vyse TJ, Botto M, Mason JC (2007) In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus. Ann Rheum Dis 66:1106–1109PubMedCrossRef
27.
Zurück zum Zitat Thorén FB, Betten A, Romero AI, Hellstrand K (2007) Cutting edge: antioxidative properties of myeloid dendritic cells: protection of T cells and NK cells from oxygen radical-induced inactivation and apoptosis. J Immunol 179:21–25PubMed Thorén FB, Betten A, Romero AI, Hellstrand K (2007) Cutting edge: antioxidative properties of myeloid dendritic cells: protection of T cells and NK cells from oxygen radical-induced inactivation and apoptosis. J Immunol 179:21–25PubMed
28.
Zurück zum Zitat Kalluri R, Cantley LG, Kerjaschki D, Neilson EG (2000) Reactive oxygen species expose cryptic epitopes associated with autoimmune goodpasture syndrome. J Biol Chem 275:20027–20032PubMedCrossRef Kalluri R, Cantley LG, Kerjaschki D, Neilson EG (2000) Reactive oxygen species expose cryptic epitopes associated with autoimmune goodpasture syndrome. J Biol Chem 275:20027–20032PubMedCrossRef
Metadaten
Titel
Catalase −262C>T polymorphism in systemic lupus erythematosus in Poland
verfasst von
Teresa Warchoł
Margarita Lianeri
Mariusz Wudarski
Jan K. Łącki
Paweł P. Jagodziński
Publikationsdatum
01.08.2008
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 10/2008
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0569-9

Weitere Artikel der Ausgabe 10/2008

Rheumatology International 10/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.